1-156130774-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_170707.4(LMNA):c.513+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_170707.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.513+1G>C | splice_donor_variant, intron_variant | Intron 2 of 11 | ENST00000368300.9 | NP_733821.1 | ||
LMNA | NM_005572.4 | c.513+1G>C | splice_donor_variant, intron_variant | Intron 2 of 9 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.513+1G>C | splice_donor_variant, intron_variant | Intron 2 of 11 | 1 | NM_170707.4 | ENSP00000357283.4 | |||
LMNA | ENST00000677389.1 | c.513+1G>C | splice_donor_variant, intron_variant | Intron 2 of 9 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change affects a donor splice site in intron 2 of the LMNA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LMNA are known to be pathogenic (PMID: 18585512, 18926329). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of LMNA-related conditions (PMID: 23360689, 24503780). ClinVar contains an entry for this variant (Variation ID: 48069). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Primary dilated cardiomyopathy Pathogenic:1
The 513+1G>C variant in LMNA has been reported in 1 Taiwanese adult with a clini cal diagnosis and family history of limb girdle muscular dystrophy, cardiac arrh ythmia, and DCM and was absent from 100 control chromosomes (Chen 2013). Data f rom large population studies is insufficient to assess the frequency of this var iant. It has been identified by our laboratory in 1 Caucasian adult with DCM an d muscular dystrophy and 1 affected relative. This variant occurs in the invaria nt region (+/- 1,2) of the splice consensus sequence and is predicted to cause a ltered splicing leading to an abnormal or absent protein. In summary, this varia nt is likely to be pathogenic, though additional studies are required to fully e stablish its clinical significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at